Cancer Epigenetics, Tumor Immunity, and Immunotherapy

被引:256
作者
Cao, Jian [1 ,2 ]
Yan, Qin [3 ]
机构
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA
[3] Yale Sch Med, Dept Pathol, Yale Canc Ctr, Yale Stem Cell Ctr, New Haven, CT 06520 USA
来源
TRENDS IN CANCER | 2020年 / 6卷 / 07期
基金
美国国家卫生研究院;
关键词
INHIBITORY RECEPTOR PD-1; CD8(+) T-CELLS; MHC CLASS-I; DNA METHYLATION; PROMOTER METHYLATION; EXPRESSION; SURVIVAL; PROCAINAMIDE; ACTIVATION; RESISTANCE;
D O I
10.1016/j.trecan.2020.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epigenetic mechanisms, including DNA methylation, histone post-translational modifications, and chromatin structure regulation, are critical for the interactions between tumor and immune cells. Emerging evidence shows that tumors commonly hijack various epigenetic mechanisms to escape immune restriction. As a result, the pharmaceutical modulation of epigenetic regulators, including 'writers', 'readers', 'erasers', and 'remodelers', is able to normalize the impaired immunosurveillance and/or trigger antitumor immune responses. Thus, epigenetic targeting agents are attractive immunomodulatory drugs and will have major impacts on immuno-oncology. Here, we discuss epigenetic regulators of the cancer-immunity cycle and current advances in developing epigenetic therapies to boost anticancer immune responses, either alone or in combination with current immunotherapies.
引用
收藏
页码:580 / 592
页数:13
相关论文
共 90 条
[1]   BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in Kras-Mutant Non-Small Cell Lung Cancer [J].
Adeegbe, Dennis O. ;
Liu, Shengwu ;
Hattersley, Maureen M. ;
Bowden, Michaela ;
Zhou, Chensheng W. ;
Li, Shuai ;
Vlahos, Raven ;
Grondine, Michael ;
Dolgalev, Igor ;
Ivanova, Elena, V ;
Quinn, Max M. ;
Gao, Peng ;
Hammerman, Peter S. ;
Bradner, James E. ;
Diehl, J. Alan ;
Rustgi, Anil K. ;
Bass, Adam J. ;
Tsirigos, Aristotelis ;
Freeman, Gordon J. ;
Chen, Huawei ;
Wong, Kwok-Kin .
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (10) :1234-1245
[2]   Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic [J].
Agrawal, Khushboo ;
Das, Viswanath ;
Vyas, Pankhuri ;
Hajduch, Marian .
PHARMACOLOGY & THERAPEUTICS, 2018, 188 :45-79
[3]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[4]   Genome-wide Analysis of Histone Methylation Reveals Chromatin State-Based Regulation of Gene Transcription and Function of Memory CD8+ T Cells [J].
Araki, Yasuto ;
Wang, Zhibin ;
Zang, Chongzhi ;
Wood, William H., III ;
Schones, Dustin ;
Cui, Kairong ;
Roh, Tae-Young ;
Lhotsky, Brad ;
Wersto, Robert P. ;
Peng, Weiqun ;
Becker, Kevin G. ;
Zhao, Keji ;
Weng, Nan-ping .
IMMUNITY, 2009, 30 (06) :912-925
[5]   Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion [J].
Bengsch, Bertram ;
Johnson, Andy L. ;
Kurachi, Makoto ;
Odorizzi, Pamela M. ;
Pauken, Kristen E. ;
Attanasio, John ;
Stelekati, Erietta ;
McLane, Laura M. ;
Paley, Michael A. ;
Delgoffe, Greg M. ;
Wherry, E. John .
IMMUNITY, 2016, 45 (02) :358-373
[6]   A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis [J].
Berg, Tobias ;
Thoene, Silvia ;
Yap, Damian ;
Wee, Tracee ;
Schoeler, Nathalie ;
Rosten, Patty ;
Lim, Emilia ;
Bilenky, Misha ;
Mungall, Andrew J. ;
Oellerich, Thomas ;
Lee, Sherry ;
Lai, Courteney K. ;
Umlandt, Patricia ;
Salmi, Anisa ;
Chang, Harry ;
Yue, Lisa ;
Lai, David ;
Cheng, S-W Grace ;
Morin, Ryan D. ;
Hirst, Martin ;
Serve, Hubert ;
Marra, Marco A. ;
Morin, Gregg B. ;
Gascoyne, Randy D. ;
Aparicio, Samuel A. ;
Humphries, R. Keith .
BLOOD, 2014, 123 (25) :3914-3924
[7]   Chromatin Architecture as an Essential Determinant of Dendritic Cell Function [J].
Boukhaled, Giselle M. ;
Corrado, Mario ;
Guak, Hannah ;
Krawczyk, Connie M. .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[8]   Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].
Brahmer, Julie R. ;
Tykodi, Scott S. ;
Chow, Laura Q. M. ;
Hwu, Wen-Jen ;
Topalian, Suzanne L. ;
Hwu, Patrick ;
Drake, Charles G. ;
Camacho, Luis H. ;
Kauh, John ;
Odunsi, Kunle ;
Pitot, Henry C. ;
Hamid, Omid ;
Bhatia, Shailender ;
Martins, Renato ;
Eaton, Keith ;
Chen, Shuming ;
Salay, Theresa M. ;
Alaparthy, Suresh ;
Grosso, Joseph F. ;
Korman, Alan J. ;
Parker, Susan M. ;
Agrawal, Shruti ;
Goldberg, Stacie M. ;
Pardoll, Drew M. ;
Gupta, Ashok ;
Wigginton, Jon M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465
[9]   DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge [J].
Castillo-Aguilera, Omar ;
Depreux, Patrick ;
Halby, Ludovic ;
Arimondo, Paola B. ;
Goossens, Laurence .
BIOMOLECULES, 2017, 7 (01)
[10]   Advances in epigenetics link genetics to the environment and disease [J].
Cavalli, Giacomo ;
Heard, Edith .
NATURE, 2019, 571 (7766) :489-499